May 1
|
GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
|
May 1
|
Trending tickers: Amazon, AMD, GSK and Aston Martin
|
May 1
|
GSK Lifts Guidance After Turnover Beats Expectations
|
Apr 30
|
Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
|
Apr 29
|
Forget the Fed. These 3 Stocks Will Soar No Matter What
|
Apr 25
|
20 Fastest Growing Health Tech Companies in the World
|
Apr 25
|
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
|
Apr 25
|
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
|
Apr 24
|
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
Mar 28
|
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
|
Mar 28
|
UPDATE 1-U.S. FDA approves Akebia's anemia drug
|
Mar 25
|
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners
|
Mar 24
|
12 Best Biotech Penny Stocks to Invest In
|
Mar 24
|
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
|
Mar 19
|
Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale
|
Mar 19
|
Pfizer Sells $3.5 Billion of Shares in Haleon
|
Mar 18
|
Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?
|
Mar 18
|
Pfizer Plans to Sell About £2 Billion of Shares in Haleon
|
Mar 16
|
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
|